Month: August 2020

Brochure on REBLOZYL Now Available

August 7, 2020 – Bristol Myers Squibb (BMS) and Acceleron have developed a brochure called “Your Guide to Starting REBLOZYL”. This brochure provides background information about ineffective erythropoiesis in thalassemia, an overview of the clinical trial findings for REBLOZYL/luspatercept in adults with transfusion-dependent beta thalassemia, a listing of the benefits and side effects of REBLOZYL […]

Read more

Secured By miniOrange